Randomized Controlled Trial
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Clin. Infect. Dis. 2012 Mar 1;54(5):621-9.
Randomized Controlled Trial
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Int. J. Antimicrob. Agents. 2008 Sep 1;32(3):241-9.
Randomized Controlled Trial
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
Lancet Infect Dis. 2014 Aug 1;14(8):696-705.